However, subsequent studies underscored the critical role of peripheral SMN restoration using MOE antisense oligonucleotides, which had the strongest effect on both survival and vascular-related clinical signs in a severe mouse model of SMA [64,65]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.